-
Jupiter Neurosciences NASDAQ:JUNS Jupiter Neurosciences, Inc. is a clinical-stage drug platform company focused on treating neuroinflammation. Our mission is to make a significant impact for patients and society through a safe and oral medication for Alzheimer’s disease and for people with rare diseases.
Location: Jupiter, Florida, United States | Website: https://jupiterneurosciences.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
30.07M
Cash
253
Avg Qtr Burn
-94.09K
Short % of Float
0.86%
Insider Ownership
54.21%
Institutional Own.
0.02%
Qtr Updated
09/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|